MCETMultiCell Technologies, Inc.

$0.00
$0.00
(0.00%)
Today
Updated: 12:57 PM EDT
Mkt Cap$5,001.00
Vol158,571.00
50

Neutral Sentiment

How do you feel about MCET?

About

MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor and MDA-5 signaling. The company was founded on April 28, 1970 and is headquartered in Dallas, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Multicell Technologies Inc?
What is the 52-week high for Multicell Technologies Inc?

Latest MCET News

View
Top Discussions

Advertisement|Remove ads.